×
S&P 500   3,829.26 (-1.82%)
DOW   31,001.22 (-1.39%)
QQQ   284.37 (-2.76%)
AAPL   137.79 (-2.73%)
MSFT   257.26 (-2.88%)
META   163.10 (-3.77%)
GOOGL   2,251.15 (-2.83%)
AMZN   107.47 (-5.08%)
TSLA   701.16 (-4.57%)
NVDA   160.17 (-5.05%)
NIO   22.38 (-2.48%)
BABA   116.94 (-1.51%)
AMD   80.87 (-6.14%)
MU   58.11 (-1.14%)
CGC   3.59 (-5.28%)
T   20.63 (-0.72%)
GE   65.81 (-1.35%)
F   11.83 (-1.74%)
DIS   96.56 (-0.05%)
AMC   13.67 (-3.26%)
PFE   50.54 (-2.58%)
PYPL   72.13 (-5.02%)
NFLX   181.85 (-3.85%)
S&P 500   3,829.26 (-1.82%)
DOW   31,001.22 (-1.39%)
QQQ   284.37 (-2.76%)
AAPL   137.79 (-2.73%)
MSFT   257.26 (-2.88%)
META   163.10 (-3.77%)
GOOGL   2,251.15 (-2.83%)
AMZN   107.47 (-5.08%)
TSLA   701.16 (-4.57%)
NVDA   160.17 (-5.05%)
NIO   22.38 (-2.48%)
BABA   116.94 (-1.51%)
AMD   80.87 (-6.14%)
MU   58.11 (-1.14%)
CGC   3.59 (-5.28%)
T   20.63 (-0.72%)
GE   65.81 (-1.35%)
F   11.83 (-1.74%)
DIS   96.56 (-0.05%)
AMC   13.67 (-3.26%)
PFE   50.54 (-2.58%)
PYPL   72.13 (-5.02%)
NFLX   181.85 (-3.85%)
S&P 500   3,829.26 (-1.82%)
DOW   31,001.22 (-1.39%)
QQQ   284.37 (-2.76%)
AAPL   137.79 (-2.73%)
MSFT   257.26 (-2.88%)
META   163.10 (-3.77%)
GOOGL   2,251.15 (-2.83%)
AMZN   107.47 (-5.08%)
TSLA   701.16 (-4.57%)
NVDA   160.17 (-5.05%)
NIO   22.38 (-2.48%)
BABA   116.94 (-1.51%)
AMD   80.87 (-6.14%)
MU   58.11 (-1.14%)
CGC   3.59 (-5.28%)
T   20.63 (-0.72%)
GE   65.81 (-1.35%)
F   11.83 (-1.74%)
DIS   96.56 (-0.05%)
AMC   13.67 (-3.26%)
PFE   50.54 (-2.58%)
PYPL   72.13 (-5.02%)
NFLX   181.85 (-3.85%)
S&P 500   3,829.26 (-1.82%)
DOW   31,001.22 (-1.39%)
QQQ   284.37 (-2.76%)
AAPL   137.79 (-2.73%)
MSFT   257.26 (-2.88%)
META   163.10 (-3.77%)
GOOGL   2,251.15 (-2.83%)
AMZN   107.47 (-5.08%)
TSLA   701.16 (-4.57%)
NVDA   160.17 (-5.05%)
NIO   22.38 (-2.48%)
BABA   116.94 (-1.51%)
AMD   80.87 (-6.14%)
MU   58.11 (-1.14%)
CGC   3.59 (-5.28%)
T   20.63 (-0.72%)
GE   65.81 (-1.35%)
F   11.83 (-1.74%)
DIS   96.56 (-0.05%)
AMC   13.67 (-3.26%)
PFE   50.54 (-2.58%)
PYPL   72.13 (-5.02%)
NFLX   181.85 (-3.85%)
NYSE:NUS

Nu Skin Enterprises Stock Forecast, Price & News

$45.05
-0.91 (-1.98%)
(As of 06/28/2022 02:44 PM ET)
Add
Compare
Today's Range
$44.96
$46.53
50-Day Range
$42.33
$48.96
52-Week Range
$39.40
$58.97
Volume
6,328 shs
Average Volume
369,934 shs
Market Capitalization
$2.26 billion
P/E Ratio
16.69
Dividend Yield
3.36%
Price Target
$61.50
30 days | 90 days | 365 days | Advanced Chart

Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

NUS Stock Forecast (MarketRank)

Overall MarketRank

3.22 out of 5 stars

Consumer Staples Sector

5th out of 195 stocks

Drugs, Proprietaries, & Sundries Industry

2nd out of 8 stocks

Analyst Opinion: 3.2Community Rank: 4.4Dividend Strength: 4.2Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -
Nu Skin Enterprises logo

About Nu Skin Enterprises (NYSE:NUS)

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

NUS Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Personal Products
CUSIP
67018T10
Employees
4,600
Year Founded
N/A

Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 6/8 Dividend
5/26/2022
Dividend Payable
6/08/2022
Today
6/28/2022
Next Earnings (Estimated)
8/03/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$61.50
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$49.00
Forecasted Upside/Downside
+36.5%
Consensus Rating
Hold
Rating Score (0-4)
2.33333333333333
Research Coverage
3 Analysts

Profitability

Net Income
$147.27 million
Pretax Margin
8.33%

Debt

Sales & Book Value

Annual Sales
$2.70 billion
Cash Flow
$5.70 per share
Book Value
$18.29 per share

Miscellaneous

Free Float
48,802,000
Market Cap
$2.26 billion
Optionable
Optionable
Beta
1.23














Nu Skin Enterprises Frequently Asked Questions

Should I buy or sell Nu Skin Enterprises stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Nu Skin Enterprises stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View analyst ratings for Nu Skin Enterprises
or view top-rated stocks.

What is Nu Skin Enterprises' stock price forecast for 2022?

3 Wall Street analysts have issued twelve-month price targets for Nu Skin Enterprises' shares. Their NUS stock forecasts range from $49.00 to $75.00. On average, they anticipate Nu Skin Enterprises' share price to reach $61.50 in the next twelve months. This suggests a possible upside of 36.5% from the stock's current price.
View analysts' price targets for Nu Skin Enterprises
or view top-rated stocks among Wall Street analysts.

How has Nu Skin Enterprises' stock price performed in 2022?

Nu Skin Enterprises' stock was trading at $50.75 at the start of the year. Since then, NUS shares have decreased by 11.2% and is now trading at $45.05.
View the best growth stocks for 2022 here
.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a decline in short interest in May. As of May 31st, there was short interest totaling 3,660,000 shares, a decline of 22.5% from the May 15th total of 4,720,000 shares. Based on an average daily volume of 604,100 shares, the days-to-cover ratio is presently 6.1 days. Approximately 7.5% of the shares of the company are sold short.
View Nu Skin Enterprises' Short Interest
.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Nu Skin Enterprises
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) released its earnings results on Wednesday, May, 4th. The company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.03. The firm earned $604.90 million during the quarter, compared to analysts' expectations of $579.70 million. Nu Skin Enterprises had a trailing twelve-month return on equity of 22.05% and a net margin of 5.28%. The business's revenue for the quarter was down 10.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.91 EPS.
View Nu Skin Enterprises' earnings history
.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises declared a quarterly dividend on Wednesday, May 4th. Shareholders of record on Friday, May 27th will be paid a dividend of $0.385 per share on Wednesday, June 8th. This represents a $1.54 dividend on an annualized basis and a dividend yield of 3.42%. The ex-dividend date is Thursday, May 26th.
View Nu Skin Enterprises' dividend history
.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises(NYSE:NUS) pays an annual dividend of $1.54 per share and currently has a dividend yield of 3.36%. Nu Skin Enterprises has been increasing its dividend for 23 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Nu Skin Enterprises is 57.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 37.65% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.
View Nu Skin Enterprises' dividend history.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of $3.60-$3.90 for the period, compared to the consensus EPS estimate of $4.21. The company issued revenue guidance of $2.51 billion-$2.62 billion, compared to the consensus revenue estimate of $2.70 billion.

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the following people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 69, Pay $827.03k)
  • Mr. Ryan S. Napierski, Pres, CEO & Director (Age 48, Pay $1.46M)
  • Mr. Mark H. Lawrence, Exec. VP & CFO (Age 52, Pay $918.58k)
  • Dr. Joseph Y. Chang Ph.D., Exec. VP & Chief Scientific Officer (Age 69, Pay $1.13M)
  • Mr. Chayce David Clark, Exec. VP & Gen. Counsel (Age 39, Pay $540.92k)
  • Mr. Ritch N. Wood, Exec. Advisor (Age 56, Pay $1.53M) (LinkedIn Profile)
  • Mr. D. Matthew Dorny, Legal Advisor (Age 58, Pay $687.56k) (LinkedIn Profile)
  • Ms. Mang Yee Tang, Exec. VP and Chief Global Growth & Customer Experience Officer (Age 51, Pay $796.45k)
  • Mr. Blake M. Roney, Founder (Age 63)
  • Ms. Sandra N. Tillotson, Founder (Age 65)

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises CEO Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among Nu Skin Enterprises' employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include State Street Corp (13.09%), Vanguard Group Inc. (12.04%), BlackRock Inc. (11.62%), Wellington Management Group LLP (7.43%), Renaissance Technologies LLC (5.36%) and Dimensional Fund Advisors LP (3.43%). Company insiders that own Nu Skin Enterprises stock include Andrew D Lipman, D Matthew Dorny, Foulis Greg, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends for Nu Skin Enterprises
.

Which institutional investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including Charles Schwab Investment Management Inc., Wellington Management Group LLP, Ergoteles LLC, UBS Group AG, Acadian Asset Management LLC, Allianz Asset Management GmbH, JPMorgan Chase & Co., and Mirabella Financial Services LLP. Company insiders that have sold Nu Skin Enterprises company stock in the last two years include Andrew D Lipman, D Matthew Dorny, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski, and Steven Lund.
View insider buying and selling activity for Nu Skin Enterprises
or view top insider-selling stocks.

Which institutional investors are buying Nu Skin Enterprises stock?

NUS stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, Invesco Ltd., Victory Capital Management Inc., Goldman Sachs Group Inc., PEAK6 Investments LLC, The Manufacturers Life Insurance Company , Cooper Creek Partners Management LLC, and Dimensional Fund Advisors LP.
View insider buying and selling activity for Nu Skin Enterprises
or or view top insider-buying stocks.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $45.05.

How much money does Nu Skin Enterprises make?

Nu Skin Enterprises (NYSE:NUS) has a market capitalization of $2.26 billion and generates $2.70 billion in revenue each year. The company earns $147.27 million in net income (profit) each year or $2.699990 on an earnings per share basis.

How many employees does Nu Skin Enterprises have?

Nu Skin Enterprises employs 4,600 workers across the globe.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The official website for Nu Skin Enterprises is www.nuskinenterprises.com. The company can be reached via phone at (801) 345-1000, via email at [email protected], or via fax at 801-345-5999.

This page (NYSE:NUS) was last updated on 6/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.